Brînduș Gabriela-Marina, Marcu Eugenia-Andreea, Olteanu Mihai, Trăistaru Magdalena Rodica
PhD Student, Doctoral School, University of Medicine and Pharmacy of Craiova, Romania.
Internal Medicine-Department of Pulmonology, University of Medicine and Pharmacy of Craiova, Romania.
Curr Health Sci J. 2022 Oct-Dec;48(4):426-435. doi: 10.12865/CHSJ.48.04.10. Epub 2022 Dec 31.
SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus-2) infection appeared for the first time in Wuhan, China in December 2019, and in March 2020 it was declared a pandemic by the World Health Organization (WHO). Thus, a new disease was registered-COVID-19 (Coronavirus Disease 2019). Our study followed the patients who had the diagnosis of obstructive ventilatory dysfunction in their personal pathological antecedents, who tested positive for SARS-CoV-2 infection. The patients were in the hospital records with chronic obstructive pulmonary disease (COPD) or asthma. After discharge, patients had a number of outstanding symptoms: fatigue, cough, dyspnea, mental and cognitive disorders, palpitations, headaches, dysfunctions of taste and smell. All patients underwent pulmonary rehabilitation after hospitalization.
In this study, we looked at the benefits of respiratory rehabilitation over a period of six months after SARS-CoV-2 infection. The medical rehabilitation program included physical training, muscle training, nutritional support, psychological support and patient education.
A retrospective study was defined between April 2021-December 2021, including 72 patients who had SARS-CoV-2 infection and who presented various symptoms on discharge. The study was carried out at the Clinical Hospital of Infectious Disease and Pneumoftiziology "Victor Babeș" from Craiova-Pulmonology Department. These patients had a history of obstructive ventilatory dysfunction: asthma or COPD. Patients were monitored during the respiratory rehabilitation program at 3 and 6 months after discharge.
An improvement in clinical and functional parameters was obtained as a result of the pulmonary rehabilitation.
Patients with COPD are increase risk to develop severe forms of COVID-19. Smoking is an important risk factor for SARS-CoV-2 infection and obstructive ventilatory dysfunction. Vaccination against SARS-CoV-2 infection is effective, being associated with mild forms of COVID-19. Pulmonary rehabilitation is a key point in the management of patients with COVID-19, improving exercise capacity, reducing dyspnea, improving health, increasing oxygen saturation and quality of life.
严重急性呼吸综合征冠状病毒2(SARS-CoV-2)感染于2019年12月首次在中国武汉出现,2020年3月世界卫生组织(WHO)宣布其为大流行病。于是,一种新疾病——2019冠状病毒病(COVID-19)被记录下来。我们的研究跟踪了个人病理史中有阻塞性通气功能障碍诊断且SARS-CoV-2感染检测呈阳性的患者。这些患者在医院记录中有慢性阻塞性肺疾病(COPD)或哮喘。出院后,患者出现了一些突出症状:疲劳、咳嗽、呼吸困难、精神和认知障碍、心悸、头痛、味觉和嗅觉功能障碍。所有患者在住院后都接受了肺康复治疗。
在本研究中,我们观察了SARS-CoV-2感染后六个月内呼吸康复的益处。医学康复计划包括体育锻炼、肌肉训练、营养支持、心理支持和患者教育。
定义了一项2021年4月至2021年12月期间的回顾性研究,纳入72例SARS-CoV-2感染且出院时出现各种症状的患者。该研究在克拉约瓦传染病和肺病临床医院“维克托·巴贝斯”肺病科进行。这些患者有阻塞性通气功能障碍病史:哮喘或COPD。在出院后3个月和6个月的呼吸康复计划期间对患者进行监测。
肺康复使临床和功能参数得到改善。
COPD患者发生重症COVID-19的风险增加。吸烟是SARS-CoV-2感染和阻塞性通气功能障碍的重要危险因素。接种SARS-CoV-2疫苗有效,与轻症COVID-19相关。肺康复是COVID-19患者管理的关键点,可提高运动能力、减轻呼吸困难、改善健康状况、提高血氧饱和度和生活质量。